BioGeneration Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Link ImmunotherapeuticsinMar 2021SEC filingmedium confidence
Seattle, US
Meininger David(Executive Officer, Director, Promoter)
BoardRoger Ulrich(Director)Daniel O'Connell(Director)
Board seatEdward van Wezel· per SEC Form D · $17.3M raise · filed Apr 2021
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.